|
 |
| home > ebr > spring 2003 > omega-3 fatty acids in the prevention of myocardial infarction |
|
|
 PUBLICATIONS |
European BioPharmaceutical Review
|
Atherosclerosis is an arterial disease causing myocardial infarction and stroke, angina pectoris and sudden death. Atherosclerosis is responsible for about 60 per cent of total mortality in the US and about 22 per cent of the population has one or more types of cardiovascular disease (1). Atherosclerosis is therefore the main threat to life and health in industrialised society today.
Sclerosis means hardening, but this pathological feature is common and in general accepted as a rather benign disease: a normal ageing of the artery. Pathologists recognise two different types of atherosclerotic plaques: large, firm plaques consisting of organised connective tissue and small, soft plaques containing lipids and inflammatory cells. The large sclerotic plaques are stable, hard structures not likely to disrupt normal function, but nevertheless show up clearly on the angiogram.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Inaugural Conference on Pre-Filled Syringes
21-22 January 2009, Crowne Plaza Hotel - St James, London, UK
SMi present their Inaugural Conference on Pre-Filled Syringes 21st and 22nd January 2009 at the Crowne Plaza Hotel - St James, London, UK
More info >> |
|
 |
News and Press Releases |
 |
Financial Times hosts the Global Pharmaceutical and Biotechnology Conference
13th November 2008
More info >> |
|
 |
